The development of more accessible artificial intelligence (AI) models has transformed the field of health diagnoses and ...

The recent CE marking under the MDR represents a significant validation of RebrAIn's strategic commitment to delivering the highest quality standards for precise and personalized neurosurgical ...

VUNO Med®-DeepCARS® (DeepCARS) is an AI-powered medical device designed to monitor the risk of in-hospital cardiac arrest within the next 24 hours. It analyzes patients' vital signs-including blood ...

Projected economic benefits of using AI-powered detection/diagnostic Software as a Medical Device, like eyonis® LCS, will be presented at ISPOR 2025, the annual conference of the leading professional ...

The Medical Crowdfunding Market encompasses online platforms and portals that enable patients, families, and healthcare providers to raise financial support for medical treatments, surgeries, ...

Fluoxetine, also known as Prozac, increased survival in a mouse model of sepsis, suggesting new therapeutic avenues for this ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

Walgreens aims to free up time for pharmacy staff, reducing their routine tasks and eliminating inventory waste.

Genfit's Iqirvo generated $26M in Q1 2025, but faces competition from Gilead’s Livdelzi, limiting its market potential. Click ...

LEIDEN, Netherlands & CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based ...

Q1 2025 pharma services revenue of $2.1 million, at 62% gross margin; Three of the top 10 U.S. transplant centers expected to participate in clinical trial; Ten globally leading t ...